Safety and efficacy of levonorgestrel implant, intrauterine device, and sterilization

Obstetrics and Gynecology

Volumn 97, Issue 4, 2001, Pages 539-547

  Meirik, Olav ^a,b   Farley, Timothy M M ^a,b   Sivin, Irving ^a,b   Akhter, H ^c   Su juan, Gu ^d   Ming kun, Du ^e   Diaz, S ^f   Campodonico, I ^g   Ojeda, G ^h   Hassan, E O ⁱ   Affandi, B ^j   Basnayake, S ^k   Koetsawang, Suporn ^m   Gill, J ⁿ   Grubb, G ^o   Fortney, J ^o   Boccard, S ^p   Pinol, A ^p  

^a UNITED NATIONS DEVELOPMENT PROGRAMME   (United States)

^b POPULATION COUNCIL   (United States)

^c Bangladesh Institute of Research for Promotion of Essential and Reproductive Health and Technologies   (Bangladesh)

^d NATIONAL RESEARCH INSTITUTE FOR FAMILY PLANNING   (China)

^e FUDAN UNIVERSITY   (China)

^f Instituto Chileno de Medicina Reproductiva   (Chile)

^g HOSPITAL SAN BORJA ARRIARÁN   (Chile)

^h Profamilia   (Colombia)

ⁱ The Egyptian Fertility Care Society   (Egypt)

^j UNIVERSITY OF INDONESIA   (Indonesia)

^k Fam Plan Association of Sri Lanka   (Sri Lanka)

^l POPULATION COUNCIL   (Thailand)

^m MAHIDOL UNIVERSITY   (Thailand)

ⁿ World Health Organization ^*

^o FAMILY HEALTH INTERNATIONAL   (United States)

^p WORLD HEALTH ORGANIZATION   (Switzerland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

COPPER INTRAUTERINE DEVICE; LEVONORGESTREL;

ADULT; ARTICLE; BORDERLINE HYPERTENSION; CLINICAL TRIAL; CONTRACEPTION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FEMALE GENITAL TRACT INFLAMMATION; FOLLOW UP; GALLBLADDER DISEASE; HUMAN; HYPERTENSION; INTERMETHOD COMPARISON; INTRAUTERINE CONTRACEPTIVE DEVICE; MAJOR CLINICAL STUDY; MORBIDITY; MULTICENTER STUDY; PREGNANCY RATE; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; RISK ASSESSMENT; UTERINE TUBE LIGATION;

ADULT; CASE-CONTROL STUDIES; COHORT STUDIES; CONTRACEPTIVE AGENTS, FEMALE; DEVELOPING COUNTRIES; DRUG IMPLANTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTRAUTERINE DEVICES; LEVONORGESTREL; STERILIZATION, TUBAL;

EID: 0035086709     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(00)01220-5     Document Type: Article

References (20)

1. Contraception with NORPLANT implants
2. International experience with NORPLANT and NORPLANT-2 contraceptives
3. A long-term follow-up study of women using different methods of contraception - An interim report
4. The Walnut Creek Contraceptive Drug Study: A prospective study of the side effects of oral contraceptives
5. Intrauterine devices and pelvic inflammatory disease: An international perspective
6. Understanding morbidity change
7. Hormonal contraception and risk of cardiovascular disease
8. Serious adverse events in Norplant users reported to the Food and Drug Administration's Med Watch Spontaneous Reporting System
9. Norplant implants and cardiovascular disease
10. Cardiovascular disease and use of oral and injectable progestogen-only contraceptives and combined injectable contraceptives
11. The effect of continuous subdermal levonorgestrel (Norplant) on carbohydrate metabolism
12. Major depression and anxiety disorders associated with Norplant
13. Meta-analyses of the relation between silicone breast implants and the risk of connective-tissue diseases
14. Oral contraception and its possible protection against rheumatoid arthritis
15. Oral contraceptives and the risk of gallbladder disease: A meta-analysis